4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
Kanabo Group Plc (KNB) operates in the Medical Care Facilities industry and is headquartered in London, United Kingdom with about 20 employees. Its market capitalization is roughly £1 million. In the fiscal year ended 2023-12-31, KNB reported £1M in revenue and (£8M) in net income.
Kanabo Group Plc, a digital health company, engages in the research, development and commercialization of cannabis-derived formulations and therapeutic inhalation devices. It operates through Primary Care and Secondary Care segments.
Interactive charts & full statements →
| Income statement | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Revenue | £1M | £1M | £0M |
| Gross Profit | £0M | £0M | £0M |
| Operating Income (EBIT) | (£3M) | (£6M) | (£3M) |
| Net Income | (£8M) | (£7M) | (£5M) |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|
| Total Assets | £8M | £14M | £6M |
| Total Liabilities | £1M | £2M | £0M |
GBP; £M / £B as marked (reporting currency). Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive KNB viewer.
About TickerBase · Data methodology & sources · Privacy · Terms